Clinical Trials Insight: 700026797
Latest Information Update: 14 Nov 2008
Price :
$35 *
At a glance
- Drugs Lapuleucel T (Primary)
- Indications Advanced breast cancer
- Focus Adverse reactions
- 06 Nov 2008 A summary of data from two phase I trials (D2000-1 and D2000-2) has been presented at the Chemotherapy Foundation Symposium, according to a Dendreon Corporation media release.
- 06 Sep 2007 New trial record.